Assignee
NANJING KAEDI BIOTHERAPEUTICS LTD
CN·3 granted patents·6 citations·filing 2018–2021
Top patents by PatentIndex Score
3 records- 0186US11359012B1Specific chimeric antigen receptor cells targeting human CLDN18A2, preparation method and application thereofNANJING KAEDI BIOTHERAPEUTICS LTD·Filed 2021·Granted Jun 14, 2022·3 cites·7 claims
- 0284US11090335B2Chimeric antigen receptor targeting human NKG2DL and methods of preparing said receptor and pharmaceutical compositionNANJING KAEDI BIOTHERAPEUTICS LTD·Filed 2018·Granted Aug 17, 2021·3 cites·7 claims
- 0353US11364267B1Bi-specific targeting human NKG2DL and CLDN18A2 chimeric antigen receptor cells, preparation method and application thereofNANJING KAEDI BIOTHERAPEUTICS LTD·Filed 2021·Granted Jun 21, 2022·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when NANJING KAEDI BIOTHERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →